SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Benchmark Initiates Coverage On Seelos Therapeutics with Speculative Buy Rating

Benchmark initiates coverage on Seelos Therapeutics (NASDAQ:SEEL) with a Speculative Buy rating.

Benzinga · -

Benchmark initiates coverage on Seelos Therapeutics (NASDAQ:SEEL) with a Speculative Buy rating.